Slingshot Biosciences has recently made headlines because of its on-demand synthetic cell platform. The biotech’s recent funding will enable the company to accelerate the commercialization of its synthetic cell products spanning controls, diagnostics, and adoptive cell therapies. Cell-derived products comprise the basis of important healthcare technologies worldwide. With respect to diagnostics, 750 blood samples are […]